These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6153224)

  • 1. Reversible low-dose bleomycin lung disease.
    Batist G
    JAMA; 1980 Jan; 243(4):331. PubMed ID: 6153224
    [No Abstract]   [Full Text] [Related]  

  • 2. Life threatening lung toxicity induced by low doses of bleomycin in a patient with Hodgkin's disease.
    Real E; Roca MJ; Viñuales A; Pastor E; Grau E
    Haematologica; 1999 Jul; 84(7):667-8. PubMed ID: 10406918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Radiographic pulmonary changes after bleomycin therapy].
    Kolmannskog F; Sortland O
    Tidsskr Nor Laegeforen; 1973 Mar; 93(9):579-82. PubMed ID: 4128184
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure.
    Bennett WM; Pastore L; Houghton DC
    Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late pulmonary toxicity of bleomycin.
    Willenbacher W; Mumm A; Bartsch HH
    J Clin Oncol; 1998 Sep; 16(9):3205. PubMed ID: 9738596
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute bleomycin lung.
    Perez-Guerra F; Harkleroad LE; Walsh RE; Costanzi JJ
    Am Rev Respir Dis; 1972 Dec; 106(6):909-13. PubMed ID: 4118373
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible pulmonary injury after a small dose of bleomycin.
    McCusker K; Dorman RA; Nicholson DP; Hough AJ
    South Med J; 1983 Nov; 76(11):1447-9. PubMed ID: 6195739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
    Cooper KR; Hong WK
    Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible penile calcifications associated with bleomycin (NSC-125066)-induced pulmonary toxicity.
    Ihde DC; Gormley PE; Francis RS; DeVita VT
    Cancer Chemother Rep; 1975; 59(5):1039-41. PubMed ID: 54214
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary function assessment during bleomycin therapy.
    Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R
    Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.
    Livingston RB; Bodey GP; Gottlieb JA; Frei E
    Cancer Chemother Rep; 1973 Apr; 57(2):219-24. PubMed ID: 4126382
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytostatic agent induced lung disease].
    Obrist R; Obrecht JP
    Dtsch Med Wochenschr; 1978 May; 103(18):765-6. PubMed ID: 77216
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleomycin in the treatment of metastatic cancer.
    Depierre A
    Prog Biochem Pharmacol; 1976; 11():195-204. PubMed ID: 63964
    [No Abstract]   [Full Text] [Related]  

  • 14. On the pathogenesis of bleomycin lung toxicity.
    Pozzi E; Zanon P
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):575-8. PubMed ID: 83311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleomycin pulmonary toxicity in adult Saudi patients with Hodgkin's lymphoma.
    Al-Jizani WA; Al-Mansour MM; Al-Fayea TM; Shafi RU; Kazkaz GA; Bayer AM; Al-Foheidi ME; Ibrahim EM
    Future Oncol; 2015; 11(15):2149-57. PubMed ID: 26235180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The place of bleomycin in the treatment of highly differentiated squamous cell cancer either alone or in combination with irradiation.
    Rygård J; Hansen HS
    Prog Biochem Pharmacol; 1976; 11():205-18. PubMed ID: 63966
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman.
    Ahmed BM; Al-Zakwani IS
    J Oncol Pharm Pract; 2013 Mar; 19(1):3-7. PubMed ID: 22504168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of bleomycin lung toxicity with corticosteroids.
    Kozielski J
    Thorax; 1994 Mar; 49(3):290. PubMed ID: 7515515
    [No Abstract]   [Full Text] [Related]  

  • 19. Late pulmonary complications of treating Hodgkin lymphoma: bleomycin-induced toxicity.
    Jóna Á; Miltényi Z; Ujj Z; Garai I; Szilasi M; Illés Á
    Expert Opin Drug Saf; 2014 Oct; 13(10):1291-7. PubMed ID: 25135756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary toxicity studies of bleomycin tested before and after its expiration date.
    Schlein A; Schurig JE; Baca CD; Bradner WT; Crooke ST
    Cancer Treat Rep; 1981; 65(7-8):727-8. PubMed ID: 6166377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.